Interleukin-31, Interleukin-31RA, and OSMR Expression Levels in Post-burn Hypertrophic Scars

키워드

참고문헌 (37)

1. Amini-Nik S, "Scar management in burn injuries using drug delivery and molecular signaling: current treatments and future directions", Adv Drug Deliv Rev, 123, pp.135~154 (2018)[DOI]
2. Bombaro KM, "What is the prevalence of hypertrophic scarring following burns?", Burns, 29, pp.299~302 (2003)[DOI]
3. Szulgit G, "Alterations in fibroblast <TEX>${\alpha}1{\beta}1$<", TEX> integrin collagen receptor expression in keloids and hypertrophic scars, 2002, pp.118, 409~415
4. Knapp TR, "Pathologic scar formation: morphologic and biochemical correlates", Am J Pathol, 86, pp.47~70 (1977)
5. Swann DA, "Studies on human scar tissue proteoglycans", J Invest Dermatol, 84, pp.527~531 (1985)[DOI]
6. Shetlar MR, "The hypertrophic scar. Glycoprotein and collagen components of burn scars", Proc Soc Exp Biol Med, 138, pp.298~300 (1971)[DOI]
7. Babu M, "Fibronectin is overproduced by keloid fibroblasts during abnormal wound healing", Mol Cell Biol, 9, pp.1642~1650 (1989)[DOI]
8. Murray JC, "Keloids and hypertrophic scars", Clin Dermatol, 12, pp.27~37 (1994)[DOI]
9. McCauley RL, "Altered cytokine production in black patients with keloids", J Clin Immunol, 12, pp.300~308 (1992)[DOI]
10. Ghahary A, "Enhanced expression of mRNA for transforming growth factor-beta, type I and type III procollagen in human post-burn hypertrophic scar tissues", J Lab Clin Med, 122, pp.465~473 (1993)
11. Xue M, "Extracellular matrix reorganization during wound healing and its impact on Abnormal Scarring", Adv Wound Care (New Rochelle), 4, pp.119~136 (2015)[DOI]
12. 최영희, "Clinical and Histological Correlation in Post-Burn Hypertrophic Scar for Pain and Itching Sensation", Annals of Dermatology, 25(4), pp.428~433 (2013), 대한피부과학회
13. Scott JR, "Making sense of hypertrophic scar: a role for nerves", Wound Repair Regen, 15(Suppl 1), pp.S27~S31 (2007)[DOI]
14. Parnell LK, "Assessment of pruritus characteristics and impact on burn survivors", J Burn Care Res, 33, pp.407~418 (2012)[DOI]
15. Profyris C, "Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part I. The molecular basis of scar formation", J Am Acad Dermatol, 66, pp.1~10 (2012)[DOI]
16. Van Loey NE, "Itching following burns: epidemiology and predictors", Br J Dermatol, 158, pp.95~100 (2008)
17. Bilsborough J, "IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis", J Allergy Clin Immunol, 117, pp.418~425 (2006)[DOI]
18. Cornelissen C, "Signaling by IL-31 and functional consequences", Eur J Cell Biol, 91, pp.552~566 (2012)[DOI]
19. Nobbe S, "IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis", Acta Derm Venereol, 92, pp.24~28 (2012)[DOI]
20. Sonkoly E, "IL-31: a new link between T cells and pruritus in atopic skin inflammation", J Allergy Clin Immunol, 117, pp.411~417 (2006)[DOI]
21. Hawro T, "Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge", Allergy, 69, pp.113~117 (2014)[DOI]
22. Dillon SR, "Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice", Nat Immunol, 5, pp.752~760 (2004)
23. Le Saux S, "Molecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis", J Biol Chem, 285, pp.3470~3477 (2010)[DOI]
24. Kwak IS, "Immunohistochemical analysis of neuropeptides (protein gene product 9.5, substance P and calcitonin gene-related peptide) in hypertrophic burn scar with pain and itching", Burns, 40, pp.1661~1667 (2014)[DOI]
25. Varney VA, "Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses", J Clin Invest, 92, pp.644~651 (1993)[DOI]
26. Kasraie S, "Functional effects of interleukin 31 in human primary keratinocytes", Allergy, 66, pp.845~852 (2011)[DOI]
27. Nattkemper LA, "Cutaneous T-cell lymphoma and pruritus: the expression of IL-31 and its receptors in the skin", Acta Derm Venereol, 96, pp.894~898 (2016)[DOI]
28. Kasutani K, "Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice", Br J Pharmacol, 171, pp.5049~5058 (2014)
29. Bando T, "Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns", Neuroscience, 142, pp.1263~1271 (2006)[DOI]
30. Steinhoff M, "Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus", J Invest Dermatol, 126, pp.1705~1718 (2006)[DOI]
31. Van Cromphaut I, "Skin barrier repair after contact burns: electrometric evaluation using the passive sustainable hydration test", J Environ Med, 1, pp.47~50 (1999)[DOI]
32. Vickery BP, "Skin barrier function in atopic dermatitis", Curr Opin Pediatr, 19, pp.89~93 (2007)[DOI]
33. Singh B, "IL-31-driven skin remodeling involves epidermal cell proliferation and thickening that lead to impaired skin-barrier function", PLoS One, 11, pp.e0161877~ (2016)[DOI]
34. Niyonsaba F, "Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells", J Immunol, 184, pp.3526~3534 (2010)[DOI]
35. Poindexter BJ, "Localization of antimicrobial peptides in normal and burned skin", Burns, 32, pp.402~407 (2006)[DOI]
36. Niyonsaba F, "Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties", Crit Rev Immunol, 26, pp.545~576 (2006)[DOI]
37. Frohm M, "The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders", J Biol Chem, 272, pp.15258~15263 (1997)[DOI]

관련 논문AI추천